Stock BOLD BOUNDLESS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Boundless Bio, Inc.

Equities

BOLD

US10170A1007

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/06/2024 BST 		5-day change 1st Jan Change
9.39 USD -2.39% Intraday chart for Boundless Bio, Inc. +3.41% 0.00%
04-22 Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target MT
04-22 Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target MT

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Guggenheim Starts Coverage on Boundless Bio With Buy Rating, $24 Price Target
MT
Piper Sandler Starts Audentes Therapeutics With Overweight Rating, $20 Price Target
MT
Boundless Bio Insider Bought Shares Worth $3,200,000, According to a Recent SEC Filing
MT
Boundless Bio Insider Bought Shares Worth $3,200,000, According to a Recent SEC Filing
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BOLD Stock
  4. News Boundless Bio, Inc.
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW